Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Octevy
- Development stage
- Unknown
- Lead developer
- Evergreen Theragnostics
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
- Administration
- Intravenous
01
Overview
Octevy is a radiopharmaceutical diagnostic agent supplied as a kit for the preparation of Gallium-68 (Ga 68) DOTATOC injection. It is designed for use with positron emission tomography (PET) imaging to localize somatostatin receptor-positive neuroendocrine tumors (NETs) in adult and pediatric patients. The kit enables radiopharmacies to prepare the injectable product on-site using an elution from a Gallium-68 generator. The mechanism of action involves targeting somatostatin receptors, which are overexpressed in many NETs, allowing precise imaging and localization of these tumors. Octevy is not yet FDA approved but has been submitted for regulatory review in the United States[1][3][6].
- Brand names
- Octevy
- Other names
- Ga 68 DOTATOC kitGa68 DOTATOC kitGa-68 DOTATOC kitKit for Preparation of Ga 68 DOTATOC Injection
02
Targets
SSTR (Somatostatin receptors)
Beyond the preview
Go deeper on Octevy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Octevy.